Chaperonin-Inspired pH Protection by Mesoporous Silica SBA-15 on Myoglobin and Lysozyme by Lynch, MM et al.
Chaperonin-Inspired pH Protection by Mesoporous Silica SBA-15 on
Myoglobin and Lysozyme
Michele M. Lynch, Jichuan Liu, Michael Nigra, and Marc-Olivier Coppens*
Department of Chemical Engineering, University College London, London WC1E 7JE, United Kingdom
*S Supporting Information
ABSTRACT: While enzymes are valuable tools in many ﬁelds
of biotechnology, they are fragile and must be protected
against denaturing conditions such as unfavorable solution pH.
Within living organisms, chaperonins help enzymes fold into
their native shape and protect them from damage. Inspired by
this natural solution, mesoporous silica SBA-15 with diﬀerent
pore diameters is synthesized as a support material for
immobilizing and protecting enzymes. In separate experiments,
the model enzymes myoglobin and lysozyme are physically
adsorbed to SBA-15 and exposed to a range of buﬀered pH
conditions. The immobilized enzymes’ biocatalytic activities
are quantiﬁed and compared to the activities of non-
immobilized enzymes in the same solution conditions. It has
been observed that myoglobin immobilized on SBA-15 is protected from acidic denaturation from pH 3.6 to 5.1, exhibiting
relative activity of up to 350%. Immobilized lysozyme is protected from unfavorable conditions from pH 6.6 to 7.6, with relative
activity of up to 200%. These results indicate that the protective eﬀects conferred to enzymes immobilized by physical adsorption
to SBA-15 are driven by the enzymes’ electrostatic attraction to the material’s surface. The pore diameter of SBA-15 aﬀects the
quality of protection given to immobilized enzymes, but the contribution of this eﬀect at diﬀerent pH values remains unclear.
■ INTRODUCTION
Nature’s Catalysts. Making chemical reactions fast,
speciﬁc, and eﬃcient has always been a top priority for
chemical engineers. Living organisms are able to do this
intrinsically through the use of enzymes, which ensure that
bioorganic reactions proceed quickly to the correct products.
Enzymes can increase rates of reaction by between 106 and 1012
times the rate of the uncatalyzed reaction, and often several
orders of magnitude greater than corresponding synthetic
catalysts. Biocatalysis makes use of enzymes, either in a puriﬁed
form or within cells, and is used extensively in the
manufacturing of ﬁne chemicals1−3 and in the synthesis of
chiral pharmaceutical intermediates.4−7
Biocatalysis provides not only high selectivity, but also mild
reaction conditions which decrease the incidence of epimeriza-
tion, isomerization, racemization, and rearrangement. Biocatal-
ysis takes place between ambient and biological temperatures,
reducing the energy needed for heating and cooling processes.
Organic solvents are used less frequently, which reduces waste
production. Biotransformations also avoid the necessity of
protecting functional groups, which reduces the raw materials
required and increases yield. Regardless of industry, biocatalysis
is central to sustainable chemistry.8−10
Enzymes have evolved to operate optimally within their host
organisms in a neutral, aqueous solution at moderate
temperature. However, these reaction conditions are incompat-
ible with most industrial processes, and exposure to extreme
conditions will result in the enzyme’s denaturation. Several
conditions lead to denaturation. In order of importance, these
are temperature, pH, detergents, and chaotropic agents.
Enzyme immobilization is the most widely used solution to
the problem of enzyme fragility. Attaching enzymes to an inert,
insoluble material can increase their operational stability.
Immobilization has the additional, signiﬁcant beneﬁt of
allowing the enzyme to be easily removed and recycled.
There are many methods of enzyme immobilization, including
covalent binding, encapsulations, cross-linking, and physical
adsorption.11−16 Often, immobilization leads to a decrease in
enzymatic activity, speciﬁcity, and selectivity. However, by
choosing the best immobilization method and material for the
given application, this attenuation can be reduced or even
inverted.17−19 Physical adsorption, such as that due to
hydrophobicity or van der Waals forces, is often too weak to
keep the enzyme ﬁxed to the carrier in industrial conditions
such as high stirring or continuous ﬂow. Ionic and covalent
binding are generally stronger, which has the advantage that the
enzyme cannot be leached from the surface. However, for
covalent binding this also has a disadvantage: if the enzyme is
irreversibly deactivated while permanently attached to the
support, then the support is rendered unusable. Ionic bonding
is therefore a suitable medium.
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Chaperonin-Inspired Enzyme Immobilization. Evolu-
tion over millennia has allowed biological systems to create
clever solutions to challenges in eﬃciency and resilience.
Drawing inspiration from nature and understanding its
fundamental concepts allows for the innovative design of
chemical engineering systems. By scientiﬁcally identifying the
fundamental mechanisms underlying desirable traits and
applying these mechanisms to the design and synthesis of
artiﬁcial systems, one can eﬃciently borrow the qualities of the
natural model.
In this investigation, molecular chaperonins inspire the
design of an eﬀective enzyme immobilization material.
Chaperonins are proteins that bind unfolded polypeptide
chains to help them fold correctly. Chaperonins are essential, as
they prevent polypeptide aggregation and precipitation by
preventing the improper association of exposed hydrophobic
segments. Chaperonins’ eﬀectiveness is due to three of their
attributes: a narrow, cylindrical pore just large enough to ﬁt a
single protein; a local electrostatic environment that encourages
rapid protein adsorption; and a hydrophilic core that
encourages the correct folding of newly synthesized pro-
teins.20,21
The immobilization material chosen for this project is rodlike
mesoporous silica SBA-15. SBA-15’s pores are block copolymer
templated; they are cylindrical and arrayed hexagonally such
that they stretch axially down the silica rod. SBA-15’s pore
diameter is sharply deﬁned and can be controlled within
nanometers upon synthesis.22 This precise control of pore
diameter is particularly useful in our chaperonin-inspired
approach, as it allows for the rational design of SBA-15 for a
target enzyme size. Further, silica is hydrophilic and negatively
charged in most solutions, resulting in a low isoelectric point.
These attributes together make it an attractive synthetic
analogue to chaperonins and a valuable candidate for enzyme
immobilization research.23−25
Enzyme immobilization onto porous supports has particular
advantages over external surface immobilization.26−29 Enzymes
on an interior surface will avoid interaction with interfaces, such
as those caused by gas bubbles or organic solvent, which can
disrupt an enzyme’s hydrophobic core.30 Previous work on
enzyme immobilization onto SBA-15 has indicated that protein
adsorption on its internal surface can be adequately described
by the Langmuir adsorption model, because the pores are not
very much larger than the protein molecules. The Langmuir ﬁt
is more accurate when the protein is adsorbed at its isoelectric
point.31,32 It has also been shown that the maximum amount of
adsorbed protein on SBA-15 is inﬂuenced more by pore volume
than surface area; that is, for suﬃciently large pores, enzymes
will pack in the available volume in the pores, rather than just
adsorb onto the interior surface.33−35
A crucial advantage of immobilization on a porous carrier is
that it can lead to “rigidiﬁcation” of the enzyme.19 By attaching
an enzyme covalently, or, to a lesser extent, ionically, at
multiple points to the material’s surface, an enzyme’s structure
is highly stabilized against conformational changes.16,30 The
eﬀect of adsorption to SBA-15 on the secondary structure of
proteins has been investigated using Fourier transform infrared
(FTIR) spectroscopy. The secondary structures of the
immobilized proteins changed in diﬀerent ways, with relative
percentages of diﬀerent motifs increasing and decreasing, but
both proteins experienced greater departures from their native
secondary structures with increasing mesoporous silica pore
diameter.36 In other words, more tightly conﬁning the proteins
resulted in better structural integrity.
The speciﬁc aim of this investigation is to help develop
mesoporous silica SBA-15 as an enzyme immobilization
material. This will be accomplished by investigating the
inﬂuence of SBA-15’s similarities to chaperonins in its ability
to protect cargo proteins from denaturation. By probing the
eﬀects of pore diameter and surface charge of the SBA-15
materials, we can achieve a better understanding of the
fundamentals behind enzyme immobilization in general, and
apply this knowledge to the design of new systems.
■ EXPERIMENTAL SECTION
Mesoporous Silica SBA-15 Synthesis and Characterization.
Rodlike mesoporous silica SBA-15 particles with narrowly controlled
pore diameters were synthesized via an acidic sol−gel method. The
temperature at which hydrothermal condensation occurs was varied
across synthesis batches to produce SBA-15 with diﬀerent average pore
diameters: batches were aged at 40, 75, or 100 °C. Additional synthetic
conditions and procedures can be found in the Supporting
Information.22,37−39
Nitrogen gas adsorption and desorption isotherms of SBA-15
samples were measured using a Quantachrome Autosorb-iQ
automated gas sorption analyzer. Samples were outgassed at 380 °C
for 8 h before analysis. The samples’ speciﬁc surface areas were
estimated using the standard Brunauer−Emmett−Teller (BET)
method,40 and the samples’ pore size distributions were calculated
using non-local density functional theory (NLDFT).41
SBA-15 external particle morphologies were observed on a JEOL
JSM-6480LV or a Zeiss EVO MA 10 scanning electron microscope
(SEM), run in high vacuum mode, typically operating at 7 kV, after
being spray-coated in gold. SBA-15 pore orientations were observed
with a JEOL 2100 transmission electron microscope (TEM) operating
at 200 kV. Before TEM analysis, samples were dispersed in ethanol
and drops of the suspension were added to holey carbon-coated
copper TEM grids. Small-angle X-ray scattering (SAXS) patterns were
obtained with a Ganesha 300XL instrument by SAXSLAB.
Enzyme Immobilization on Mesoporous Silica SBA-15.
Sodium phosphate monobasic (NaH2PO4) (BioXtra, ≥ 99%), sodium
phosphate dibasic (Na2HPO4) (BioXtra, ≥ 99%), glacial acetic acid
(ACS reagent, ≥ 99.7%), sodium acetate (≥99%, anhydrous),
myoglobin from equine heart (≥90%, essentially salt-free, lyophilized
powder), and lysozyme from chicken egg white (lyophilized powder,
protein content ≥90%, ≥ 40,000 units/mg protein) were purchased
from Sigma-Aldrich.
To test the protective eﬀects of SBA-15 on immobilized enzyme,
myoglobin/SBA-15 and lysozyme/SBA-15 composites were prepared
with a target loading of 50 mg of enzyme per gram of SBA-15 in
phosphate buﬀer. First, SBA-15 was suspended in phosphate buﬀer
(pH 7.2, I = 0.1) at a concentration of 4 g/L and sonicated to ensure
that it was well dispersed. Enzyme solutions were prepared in the same
buﬀer at 0.2 g/L. The SBA-15 solution was then mixed with an equal
volume of enzyme solution for a ﬁnal SBA-15 concentration of 2 g/L
and enzyme concentration of 0.1 g/L. This composite solution was
agitated overnight at room temperature to ensure equilibrium.
After the enzyme had adsorbed to the SBA-15 over 24 h, the
solutions were centrifuged at 12 000 rpm for 5 min, and the
supernatant and pelleted SBA-15 were separated. The concentration of
enzyme in the supernatant was measured via ultraviolet−visible (UV−
vis) spectrophotometry at a characteristic absorbance wavelength of
280 nm (and also 409 nm for myoglobin). UV−vis spectroscopy was
carried out using the absorbance mode of a BioTek Synergy H1Multi-
Detection Reader. These measurements were compared to a
calibration curve, and the enzyme concentrations were determined
by the Beer−Lambert law. The amount of enzyme adsorbed to the
SBA-15 was calculated using a mass balance.33
Exposure of Immobilized Enzymes to Unfavorable pH. Next,
myoglobin/SBA-15 and lysozyme/SBA-15 composites were prepared
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and exposed to a range of pH conditions. The enzyme/SBA-15
composites were resuspended to 2 g/L in either acetate or phosphate
buﬀers of varying pH, but all of I = 0.1. Acetate buﬀers were prepared
by mixing a 100 mM solution of acetic acid and a 100 mM solution of
sodium acetate to make buﬀers with ﬁnal pH values of 3.6, 4.1, 4.6, 5.1,
and 5.6. Phosphate buﬀers were prepared by mixing a 100 mM
solution of sodium phosphate monobasic and a 33.3 mM solution of
sodium phosphate dibasic to make buﬀers with ﬁnal pH values of 5.6,
6.1, 6.6, and 7.6. All of these buﬀer solutions necessarily have I = 0.1.
After the enzyme/SBA-15 composites were agitated for 24 h at
room temperature in their test buﬀers, they were centrifuged again.
The supernatant was saved and measured with UV−vis to determine
enzyme leaching. The pellets were resuspended in the same buﬀers (of
varying pH values), and their enzymatic activity was immediately
quantiﬁed. Each combination of pore size, pH, and enzyme was
prepared in triplicate. Myoglobin containing samples were additionally
measured in triplicate.
These experimental conditions were replicated for 0.1 g/L solutions
of free myoglobin or lysozyme in the same series of buﬀers, as
controls. In these experiments, lyophilized enzyme was suspended
directly into the acetate or phosphate buﬀers of varying pH values, and
agitated for 24 h at room temperature. Then, each solution’s enzymatic
activity was quantiﬁed.
For myoglobin-containing samples, enzymatic activity was quanti-
ﬁed using a colorimetric, peroxidase assay indicated with 2,2′-azino-
bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS). For lysozyme-
containing samples, activity was quantiﬁed using a ﬂuorometric,
glycanase assay indicated with 4-methylumbelliferyl β-D-N,N′,N′-
triacetylchitotrioside. Both assays were monitored with a BioTek
Synergy H1Multi-Detection Reader. More information on these assays
can be found in the Supporting Information.
To conﬁrm the SBA-15 samples’ colloidal stability in the
aforementioned acetate or phosphate buﬀers, separately prepared 2
g/L samples of each batch of SBA-15 in each buﬀer were measured
with dynamic light scattering (DLS) with a Brookhaven NanoBrook
Omni particle sizer to determine their particle size and check for
aggregation. The sample solutions were sonicated prior to measure-
ment. No aggregation was observed in any buﬀer for any sample, as
the average hydrodynamic diameter of the particles agreed with the
particle dimensions observed in SEM.
■ RESULTS AND DISCUSSION
Mesoporous Silica SBA-15 Characterization. For
porous materials, nitrogen physisorption can be used to
determine the shape, size, and volume of the pores, and the
material’s total surface area. Nitrogen adsorption and
desorption isotherms of all SBA-15 samples contain hysteresis
loops deﬁned as type H1 by the IUPAC classiﬁcation, which is
associated with well-deﬁned cylindrical pore channels.42 These
adsorption and desorption isotherms can be found in the
Supporting Information.
The narrow pore size distributions shown in Figure 1,
calculated by the NLDFT method, indicate good control of the
SBA-15’s mesopore diameter. As found in other studies, pore
size increases at higher hydrothermal aging temperatures.37
Table 1 shows the morphological parameters derived from
nitrogen physisorption of all SBA-15 samples. Total surface
area, calculated by the BET method, increases with increasing
synthesis temperature for all SBA-15 batches. The volume of
pores smaller than 50 nm also increases with increasing
synthesis temperature for all samples. These pore volume
values include micropores (<2 nm in diameter) and mesopores
(2−50 nm in diameter). No appreciable macropore volume is
observed for any sample.
SEM is used to determine the external morphology and
particle dimensions for the synthesized SBA-15 materials. SEM
shows that all SBA-15 particles have a rodlike morphology and
that their particle size distributions have low polydispersity. A
single SBA-15 particle is approximately 1 μm in length. From
these micrographs, it appears that the hydrothermal aging
temperature aﬀects the particles thickness: SBA-15_40C
particles have an approximate diameter of 400 nm, while
SBA-15_100C particles have an approximate diameter of 300
nm. SEM micrographs can be found in the Supporting
Information.
TEM is used to observe the internal morphology of the
synthesized SBA-15 particles and shows the orientation and
shape of their internal pores. Pores are found to be oriented
down the length of the rodlike particles, and very low tortuosity
of the pores is observed. TEM micrographs can be found in the
Supporting Information.
SAXS patterns of the three conventionally synthesized SBA-
15 materials show that all three samples have an ordered pore
structure. SBA-15 is known to have hexagonally ordered,
cylindrical parallel pores, corresponding to the p6mm space
group. The Miller indices of the three peaks found in SBA-15
SAXS spectra are then (100), (110), and (200).32 Unit cell
dimensions can be calculated from these peaks. The pore wall
thicknesses for all SBA-15 batches are very similar. SAXS
spectra and derived data can be found in the Supporting
Information.
Acidic Protection of Immobilized Myoglobin. Myoglo-
bin immobilized on SBA-15 of diﬀerent pore diameters is
exposed to a range of pH conditions, and then its peroxidase
activity is measured by assay at that pH. This is done to
examine the relationship between pH and immobilized enzyme
activity, and probe for possible protective eﬀects of SBA-15 on
the immobilized enzymes from denaturing acidic and alkaline
conditions. Myoglobin loading onto SBA-15 is targeted for 50
mg per gram of SBA-15.
Figure 2a shows the peroxidase activity of free myoglobin, as
well as of myoglobin immobilized on SBA-15 of diﬀerent pore
diameters. The activity is shown in arbitrary units, proportional
Figure 1. NLDFT pore size distributions of mesoporous silica SBA-15,
synthesized at 40, 75, and 100 °C, derived from N2 adsorption.
Table 1. Textural Parameters Derived from N2 Adsorption
of Mesoporous Silica SBA-15 Particles Synthesized at 40, 75,
and 100 °C
synthesis
temperature
(°C)
NLDFT pore
diameter (nm)
BET surface
area (m2/g)
micro- and mesopore
volume (cm3/g)
40 6.1 505 0.491
75 6.6 602 0.656
100 8.1 685 1.093
Langmuir Article
DOI: 10.1021/acs.langmuir.6b02832
Langmuir 2016, 32, 9604−9610
9606
Figure 2. (a) Peroxidase activities of free myoglobin and myoglobin immobilized to mesoporous silica SBA-15, with pore diameters of 6.1, 6.6, and
8.1 nm, in solutions of varying pH (3.6 to 7.6) at ionic strength 0.1. (b) Relative peroxidase activity of the same samples. Error bars depict 95%
conﬁdence intervals.
Figure 3. (a) Glycanase activities of free lysozyme and lysozyme immobilized on mesoporous silica SBA-15, with pore diameters of 6.1, 6.6, and 8.1
nm, in solutions of varying pH (3.6 to 7.6) at ionic strength 0.1. (b) Relative glycanase activity of the same samples. Error bars depict 95%
conﬁdence intervals.
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to the rate of the peroxidase reaction (absorbance per second)
and divided by the concentration of myoglobin in the sample
(g/L). At pH 5.6, samples are prepared in both phosphate and
acetate buﬀers, at the same ionic strength, and the samples’
activities are found to be within error of each other. This alone
is a useful ﬁnding, as it suggests that the buﬀer salt used does
not have a signiﬁcant eﬀect on the enzyme’s activity.
Myoglobin acts as a peroxidase on the ABTS substrate most
eﬀectively between pH 5.1 and 5.6, as can be seen by the free
myoglobin bars in Figure 2a. This optimal activity decreases
slowly at more alkaline pH values, but rapidly at more acidic
pH values. The quick decrease in activity may be attributed to
the denaturation of myoglobin in acidic conditions. From this
graph we can see that myoglobin immobilized on SBA-15
performs signiﬁcantly worse than myoglobin free in aqueous
solution and at its optimal pH.
Figure 2b depicts the same data, shown normalized to the
activity of the free myoglobin at each pH. The activity of
conﬁned myoglobin surpasses that of free myoglobin at low pH
values, up to 350%. This indicates that conﬁned myoglobin is
protected, to some extent, from denaturing due to the acidic
environment. Immobilized myoglobin does not enjoy this
protective eﬀect at pH values greater than 5.1.
Focusing solely on the acidic pH range where immobilized
myoglobin’s activity exceeds that of free myoglobin, we can see
in the inset of Figure 2b that the protective eﬀect appears to
diminish as the pH decreases. We can also see that, for this set
of experiments, pH protection does not appear to be aﬀected
signiﬁcantly by the SBA-15’s pore size. Immobilization onto
SBA-15 does not improve myoglobin’s peroxidase activity at all
pH values tested. However, conﬁnement to SBA-15 does shift
the eﬀective activity range of myoglobin to more acidic pH
values with dramatic protection up to 350%.
Some myoglobin leaching is observed during the pH
exposure step; these data can be found in the Supporting
Information. Leaching is accounted for in the activity
measurements. Myoglobin leaching remains under 15% for
almost all SBA-15 samples in most batches. More leaching is
observed from all SBA-15 at the higher pH values of 7.2 and
7.6. This is to be expected, as myoglobin will have a net neutral
charge near these pH values and not be as strongly attracted to
the negatively charged silica surface. These data are also helpful
in conﬁrming that the diﬀerent SBA-15 batches have similar
surface charge proﬁles. If the materials had very diﬀerent
surface charges, then the amount of myoglobin leached at
diﬀerent pH values should also be diﬀerent because the
leaching is shown to be very dependent on the extent of
electrostatic attraction between the protein and the material
surface. Since the amount of myoglobin leached at each pH is
within error between the diﬀerent SBA-15 batches, the
materials’ surface charge at each pH must be very similar.
Alkaline Protection of Immobilized Lysozyme. To
further investigate the relationship between pH and immobi-
lized enzyme activity, and probe for possible protective eﬀects
of SBA-15, lysozyme is also immobilized on SBA-15 of diﬀerent
pore diameters and exposed to a range of pH conditions. Then,
their glycanase activity is measured by an assay at that pH. As
with myoglobin, lysozyme loading onto SBA-15 is targeted for
50 mg per gram of SBA-15.
Figure 3a shows the glycanase activity of free lysozyme, as
well as of lysozyme immobilized on SBA-15 of diﬀerent pore
diameters. The activity is shown in arbitrary units proportional
to the speed of the glycanase reaction (ﬂuorescence, F, per
minute) divided by the concentration of lysozyme in the
sample (g/L). Small amounts of lysozyme leaching are
observed while the samples are left in the test buﬀer for 24
h. Leaching is always accounted for in speciﬁc activity
calculations. At pH 5.6, both phosphate and acetate buﬀers
are used at the same ionic strength. In these buﬀers, the
sample’s activities are found to be within error of each other.
Again, this is useful as it suggests that the buﬀer salt used does
not have a signiﬁcant eﬀect on lysozyme’s activity.
Lysozyme acts as a glycanase on the ﬂuorogenic substrate
most eﬀectively between pH 4.6 and 5.1, as can be seen by the
free lysozyme bars in Figure 3a. This optimal activity drops oﬀ
more slowly at lower and higher pH values than that of
myoglobin; this makes sense, because myoglobin has evolved to
operate in a very speciﬁc pH environment inside of muscle
tissue (pH 7.2), whereas lysozyme must remain functional
within the larger range of pH values found in egg whites (pH
7.6 to 9.8).
Figure 3b depicts the same data, shown normalized to the
activity of the free lysozyme at each pH. The activity of
conﬁned lysozyme surpasses that of free lysozyme at pH values
that are more alkaline than the optimal pH, up to 200%. This
implies that conﬁned lysozyme is protected to some extent.
Protective eﬀects are not clearly evident at pH values below 6.6.
However, lysozyme immobilized on SBA-15_6.6 nm always
performs at least as well as, if not better than, free lysozyme.
SBA-15_6.6 nm also shows protective eﬀects against more
acidic conditions at pH 3.6 and 4.1. This is a unique result, and
may indicate that this particular pore diameter is especially
suited to stabilize and improve the glycanase activity of
lysozyme for reasons that are not yet fully understood.
Focusing speciﬁcally on the pH range where SBA-15
demonstrates some protective eﬀects on lysozyme, on the
more alkaline side of the assay’s optimal pH, we see that, in
many cases, the activities of lysozyme immobilized on SBA-
15_5.7 nm and SBA-15_8.1 nm are within error of that of free
lysozyme. This is a modest but positive result, as at least
immobilization does not hinder the enzyme’s activity and it can
still be more easily reused.
The pore size of the SBA-15 does appear to play a role in the
extent to which lysozyme’s activity is modiﬁed. Particularly at
pH 6.6, we can see a clear trend of larger pore sizes leading to a
greater increase in activity. Immobilization onto SBA-15 does
not improve lysozyme’s glycanase activity at all pH values
tested. However, conﬁnement to SBA-15 does widen
lysozyme’s eﬀective activity range, with substantial alkaline
protection up to 200%.
Some lysozyme leaching is observed while the samples are
left in the test buﬀer for 24 h, which is accounted for in speciﬁc
activity calculations. These data can be found in the Supporting
Information. Lysozyme leaching exceeds that of myoglobin at
some pH values, leaching up to 60% at the low pH of 3.6. At
low pH values, lysozyme will be very strongly positively
charged, while the silica surface will be weakly negative. The
increased leaching may be caused by the lysozyme−lysozyme
repulsion superseding the lysozyme−silica attraction. As with
the myoglobin leaching data, these data are also helpful in
conﬁrming that the diﬀerent SBA-15 batches have similar
surface charge proﬁles.
Electrostatics Drives pH Protection. The results of this
study give insight into which aspects of the immobilization
material are most important for predicting and tuning
protective eﬀects.
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Mesoporous silica’s isoelectric point is typically found around
pH 2. Myoglobin’s isoelectric point is 7.2. In any solution
between pH 2 and 7.2, mesoporous silica has a negative net
surface charge and myoglobin has a positive net surface charge,
and the myoglobin molecules are electrostatically attracted to
the silica surface. This attraction will be strongest at the center
of this pH range. We found that myoglobin immobilized to
SBA-15 demonstrated the highest activity, or the strongest
protective eﬀects, at pH 5.1. As seen in Scheme 1, this
corresponds directly to the pH value at which myoglobin and
mesoporous silica experience the strongest electrostatic
attraction.
A similar argument can be made for lysozyme, whose
isoelectric point is 11.3. Therefore, in any aqueous solution
between pH 2 and 11.3, mesoporous silica has a negative net
surface charge and lysozyme has a positive net surface charge,
so that lysozyme molecules are electrostatically attracted to the
silica surface. Our experiments showed that lysozyme
immobilized to SBA-15 demonstrated the highest relative
activity, corresponding to the strongest protective eﬀects, at pH
6.6, as seen in Scheme 2. Again, this correlates directly to the
pH value at which lysozyme and mesoporous silica experience
the strongest electrostatic attraction. Together these two sets of
results indicate that electrostatic attraction drives the increased
enzymatic activity observed when immobilizing either enzyme
with the physical adsorption method, a result that is likely to be
more general.
■ SUMMARY AND CONCLUSIONS
This paper discussed pH protection of enzymes by
immobilization on the pore surface of mesoporous silica with
controlled pore diameters slightly larger than the size of the
enzymes. Batches of ordered mesoporous silica SBA-15 with
diﬀerent, unique pore diameters were synthesized by a
templated sol−gel method. The materials were characterized
using N2 gas adsorption, SEM, TEM, SAXS, and DLS.
Immobilizing two common enzymes, lysozyme and
myoglobin, to SBA-15 was shown to increase their biocatalytic
activity under some solution conditions, compared to the
activity of the same enzyme free in the same solution. For
myoglobin, these protective eﬀects were observed on the acidic
side of the pH range tested (pH 3.6 to 5.6). For lysozyme, the
protective eﬀects were seen on the alkaline side of the pH range
tested (pH 5.1 to 7.6). For both enzymes, the protective eﬀects
were strongest for pH values where the enzyme is strongly
electrostatically attracted to the silica surface. The diﬀerent
buﬀer salts used, acetate and phosphate, were not found to
signiﬁcantly aﬀect enzyme leaching or activity. Pore size may
aﬀect SBA-15 pH protective eﬀects, as seen with lysozyme, but
further work is required to validate this.
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